Learn more about the 2025 immunization program landscape in AIM’s 2025 Annual Survey Aggregate Report. AIM’s 2025 annual survey assessed and characterized immunization program (IP) policy, infrastructure, program activities, priorities, and the impact of funding changes (both federal and state) on IPs. AIM administers the survey annually to document changes over time within IPs.

Information gathered from the survey is used to generate reports and presentations on the status of IPs and to respond to inquiries from partners, Congressional staff, the media, and others. The response rate for 2025 was 96% with 63 of 66 IPs completing the survey.

Compare the 2025 results to the 2024 Annual Survey Aggregate Report.

On April 14, AIM hosted a data-focused webinar, Unpacking the 2025 AIM Annual Survey: Trends, Challenges, and What’s Ahead. In this webinar, AIM staff shared key findings from the 2025 AIM Annual Survey.

With 96% of state, local, and territorial immunization programs participating in the 2025 AIM Annual Survey, this webinar offered insight into the current national programmatic landscape related to adult, Vaccines for Children (VFC), Immunization Information Systems (IIS), and HPV activities, state and Section 317 funding contributions, coverage improvement strategies, and roles of state advisory boards.

The 2025 AIM Annual Survey Snapshot is a high-level overview of the results of the 2025 Annual Survey. The snapshot contains easy-to-read data about the immunization environment, current challenges, and more. Immunization program (IP) infrastructure and funding, priorities, and activities are highlighted visually.

Summarized survey results included in the snapshot:

• Number of IPs receiving state or local funding support
• Position vacancies
• Program manager turnover
• Program staff size
• Advisory board activities
• Program priorities for 2026
• Number of immunization programs conducting activities related to:
  • immunization information systems (IIS)
  • adult immunization
  • childhood/adolescent immunization
  • vaccine access
  • state legislative sessions